Second Sight Medical Products Inc (NASDAQ:EYES)
| 0.822 Delayed Data As of Dec 06 |  +0.0122 / +1.51%Today’s Change | 0.64 Today|||52-Week Range 1.20 | -7.17% Year-to-Date |
Latest EYES News | Press Releases
No recent news for Second Sight Medical Products Inc.
Today’s Trading
| Previous close | 0.81 |
| Today’s open | 0.80 |
| Day’s range | 0.78 - 0.83 |
| Volume | 176,344 |
| Average volume (3 months) | 191,251 |
| Market cap | $108.1M |
Data as of 4:00pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | +0.25% |
| Earnings growth (this year) | +41.30% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -13.41% |
| P/E ratio | NM |
| Price/Sales | 8.52 |
| Price/Book | 21.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CFMSConformis Inc | -0.07 | -4.29% |
| ENLVEnlivex Therapeutics... | +0.04 | +0.51% |
| EDAPEdap Tms SA | +0.04 | +0.84% |
| APENApollo Endosurgery I... | +0.05 | +1.89% |
Data as of 4:00pm ET, 12/06/2019
Financials
| Next reporting date | March 5, 2020 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$35.1M |
| Net profit margin | -508.90% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Sylmar, California |
Forecasts
